Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 4, 2012, Pages 520-525

  Vanlander, A V ^a   Jorens, P G ^b   Smet, J ^a   De Paepe, B ^a   Verbrugghe, W ^b   Van Den Eynden, G G ^c   Meire, F ^d   Pauwels, P ^c   Van Der Aa, N ^b   Seneca, S ^e   Lissens, W ^e   Okun, J G ^f   Van Coster, R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; PROPOFOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REMIFENTANIL; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; ARTICLE; BRADYCARDIA; CASE REPORT; CEREBROSPINAL FLUID DRAINAGE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DECOMPRESSIVE CRANIECTOMY; DRUG WITHDRAWAL; ENZYME ACTIVITY; HEAD INJURY; HUMAN; HUMAN TISSUE; INJURY SEVERITY; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MUSCLE BIOPSY; OXIDATIVE PHOSPHORYLATION; POINT MUTATION; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RENAL REPLACEMENT THERAPY; RHABDOMYOLYSIS; RISK FACTOR; SKELETAL MUSCLE; TRAFFIC ACCIDENT;

ADULT; ANESTHETICS, INTRAVENOUS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MUSCLE, SKELETAL; OPTIC ATROPHY, HEREDITARY, LEBER; OXIDATIVE PHOSPHORYLATION; PROPOFOL; RISK FACTORS; SYNDROME; UBIQUINONE;

EID: 84857288277     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2011.02628.x     Document Type: Article

References (34)

1. Vasile B, Rasulo F, Candiani A, Latronico N,. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003; 29: 1417-1425.
2. Diedrich DA, Brown DR,. Analytic reviews: propofol infusion syndrome in the ICU. J Intensive Care Med 2011; 26: 59-72.
3. Branci D, Roberti MS, Vincenti E, Scutari G,. Uncoupling effect of the general anesthetic 2,6-diisopropylphenol in isolated rat liver mitochondria. Arch Biochem Biophys 1991; 290: 517-521.
4. Rigoulet M, Devin A, Avéret N, Vandais B, Guérin B,. Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. Eur J Biochem 1996; 241: 280-285.
5. Schenkman KA, Yan S,. Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy. Crit Care Med 2000; 28: 172-177.
6. Mehta N, Demunter C, Habibi P, Nadel S, Britto J,. Short-term propofol infusions in children. Lancet 1999; 354: 866-867.
7. Cray SH, Robinson BH, Cox PN,. Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit Care Med 1998; 26: 2087-2092.
8. Finsterer J, Segall L,. Drugs interfering with mitochondrial disorders. Drug Chem Toxicol 2010; 33: 138-151.
9. Howell N, Bindoff LA, McCullough DA, Kubacka I, Mackey D, Taylor L, Turnbull DM,. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991; 49: 939-950.
10. Van Coster R, Smet J, George E, De Meirleir L, Seneca S, Van Hove J, Sebire G, Verhelst H, De Bleecker J, Van Vlem B, Verloo P, Leroy J,. Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects. Pediatr Res 2001; 50: 658-665.
11. Court MH, Hay-Kraus BL, Hill DW, Kind AJ, Greenblatt DJ,. Propofol hydroxylation by dog liver microsomes: assay development and dog breed differences. Drug Metab Dispos 1999; 27: 1293-1299.
12. Adverse effects of propofol (Diprivan). Ugeskr Laeger 1990; 152: 1176.
13. Parke TJ, Stevens JE, Rice AS, Greenaway CL, Bray RJ, Smith PJ, Waldmann CS, Verghese C,. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992; 305: 613-616.
14. Bray RJ,. Propofol infusion syndrome in children. Paediatr Anaesth 1998; 8: 491-499.
15. Marinella MA,. Lactic acidosis associated with propofol. Chest 1996; 109: 292.
16. Eriksen J, Povey HM,. A case of suspected non-neurosurgical adult fatal propofol infusion syndrome. Acta Anaesthesiol Scand 2006; 50: 117-119.
17. Motsch J, Roggenbach J,. Propofol-Infusionssyndrom. Anaesthesist 2004; 53: 1009-1024.
18. Jorens PG, Van Den Eynden G,. Propofol infusion syndrome with arrhythmia, myocardial fat accumulation and cardiac failure. Am J Cardiol 2009; 104: 1160-1162.
19. Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS,. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem 2000; 46: 577-581.
20. Acco A, Bracht A,. Transport, transformation and distribution space of propofol in the rat liver studied by means of the indicator-dilution technique. Xenobiotica 2004; 34: 317-334.
21. Marian M, Parrino C, Leo AM, Vincenti E, Bindoli A, Scutari G,. Effect of the intravenous anesthetic 2,6-diisopropylphenol on respiration and energy production by rat brain synaptosomes. Neurochem Res 1997; 22: 287-292.
22. Withington DE, Decell MK, Al Ayed T,. A case of propofol toxicity: further evidence for a causal mechanism. Paediatr Anaesth 2004; 14: 505-508.
23. Wolf A, Weir P, Segar P, Stone J, Shield J,. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 2001; 357: 606-607.
24. Kam PC, Cardone D,. Propofol infusion syndrome. Anaesthesia 2007; 62: 690-701.
25. Laquay N, Prieur S, Greff B, Meyer P, Orliaguet G,. Propofol infusion syndrome. Ann Fr Anesth Reanim 2010; 29: 377-386.
26. Pello R, Martín MA, Carelli V, Nijtmans LG, Achilli A, Pala M, Torroni A, Gõmez-Durán A, Ruiz-Pesini E, Martinuzzi A, Smeitink JA, Arenas J, Ugalde C,. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum Mol Genet 2008; 17: 4001-4011.
27. Rodenburg RJ,. Biochemical diagnosis of mitochondrial disorders. J Inherit Metab Dis 2011; 34: 283-292.
28. Brown MD, Trounce IA, Jun AS, Allen JC, Wallace DC,. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Lebers hereditary optic neuropathy mitochondrial DNA mutation. J Biol Chem 2000; 275: 39831-39836.
29. Levy RJ,. Clinical effects and lethal and forensic aspects of propofol. J Forensic Sci 2011; 56: S142-147.
30. Roberts RJ, Barletta JF, Fong JJ, Schumaker G, Kuper PJ, Papadopoulos S, Yogaratnam D, Kendall E, Xamplas R, Gerlach AT, Szumita PM, Anger KE, Arpino PA, Voils SA, Grgurich P, Ruthazer R, Devlin JW,. Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care 2009; 13: R169.
31. Cooper MA, Fox R,. Anesthesia for corrective spinal surgery in a patient with Leighs disease. Anesth Analg 2003; 97: 1539-1541.
32. Sasano N, Fujita Y, So MH, Sobue K, Sasano H, Katsuya H,. Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode (MELAS) during laparotomy. J Anesth 2007; 21: 72-75.
33. Park JS, Baek CW, Kang H, Cha SM, Park JW, Jung YH, Woo YC,. Total intravenous anesthesia with propofol and remifentanil in a patient with MELAS syndrome-a case report. Korean J Anaesthesiol 2010; 58: 409-412.
34. Cheam EW, Critchley LA,. Anesthesia for a child with complex I respiratory chain enzyme deficiency. J Child Anaesthesia 1998; 10: 524-527.